"On October 19, 2022, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the September 12, 2022 letter of authorization in its entirety to authorize the use of Novavax COVID‑19 Vaccine"
Scroll down this URL and read some of the EUAs. https://www.fda.gov/emergency-preparedness-and-response/mcm-...
"On October 19, 2022, having concluded that revising this EUA is appropriate to protect the public health or safety under section 564(g)(2) of the Act, FDA is reissuing the September 12, 2022 letter of authorization in its entirety to authorize the use of Novavax COVID‑19 Vaccine"